These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3668390

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Animal and cellular models of sphingolipid storage disorders of humans.
    Gal AE, Weis AL, Quirk JM, Tokoro T, Brady RO.
    Chem Phys Lipids; 1986 Dec 15; 42(1-3):199-207. PubMed ID: 3829206
    [Abstract] [Full Text] [Related]

  • 4. Comparison of synthetic and natural glucosylceramides as substrate for glucosylceramidase assay.
    Vaccaro AM, Kobayashi T, Suzuki K.
    Clin Chim Acta; 1982 Jan 05; 118(1):1-7. PubMed ID: 7053901
    [Abstract] [Full Text] [Related]

  • 5. Animal and cellular models of Gaucher's disease. I. Refractoriness of thio analogs of glucocerebroside to enzymatic hydrolysis.
    Quirk JM, Weis AL, Shapiro D, Brady RO.
    Biotechnol Appl Biochem; 1986 Feb 05; 8(1):96-100. PubMed ID: 3828086
    [Abstract] [Full Text] [Related]

  • 6. L-glucosylceramide: synthesis, properties, and resistance to catabolism by glucocerebrosidase in vitro.
    Gal AE, Pentchev PG, Massey JM, Brady RO.
    Proc Natl Acad Sci U S A; 1979 Jul 05; 76(7):3083-6. PubMed ID: 290986
    [Abstract] [Full Text] [Related]

  • 7. Comparison of rates of hydrolysis of N-oleoyl and N-stearoyl glucocerebroside in patients with Gaucher's disease.
    Peters SP, Aquino L, Naccarato WF, Gilbertson JR, Diven WF, Glew RH.
    Biochim Biophys Acta; 1979 Oct 26; 575(1):27-36. PubMed ID: 508779
    [Abstract] [Full Text] [Related]

  • 8. Lessons from glucosylceramide and Gaucher's disease.
    Luft FC.
    J Mol Med (Berl); 1998 Oct 26; 76(11):723-4. PubMed ID: 9826117
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Normalization of liver glucosylceramide levels in the "Gaucher" mouse by phosphatidylserine injection.
    Datta SC, Radin NS.
    Biochem Biophys Res Commun; 1988 Apr 15; 152(1):155-60. PubMed ID: 3358758
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gaucher's disease and cancer: a sphingolipid perspective.
    Barth BM, Shanmugavelandy SS, Tacelosky DM, Kester M, Morad SA, Cabot MC.
    Crit Rev Oncog; 2013 Apr 15; 18(3):221-34. PubMed ID: 23510065
    [Abstract] [Full Text] [Related]

  • 16. Studies on the etiology of Gaucher's disease. 1. Catabolism of glycolipids by rat liver in vivo.
    Statter M, Shapiro B.
    Isr J Med Sci; 1965 Jul 15; 1(4):514-20. PubMed ID: 5891589
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants.
    Nilsson O, Grabowski GA, Ludman MD, Desnick RJ, Svennerholm L.
    Clin Genet; 1985 May 15; 27(5):443-50. PubMed ID: 3924448
    [Abstract] [Full Text] [Related]

  • 19. The distribution of glucocerebroside in the liver of patients with Gaucher's disease.
    Gal AE, Pentchev PG, Barranger JA, Dambrosia JM, Brady RO.
    Anal Biochem; 1979 May 15; 95(1):127-32. PubMed ID: 495946
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.